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Background. The Inflammatory Bowel Diseases, including both Ulcerative Colitis and 
Crohn’s Disease, are lifelong disorders of the Gastrointestinal tract. In recent 
years, both conditions have become much more prevalent and recognized as 
major public health issues. Environmental factors have become the focus of recent 
research around the cause of these diseases. Although shown to have detrimental 
effects on diseases similar to that of the Inflammatory Bowel Diseases, fine 
particulate matter’s role in these diseases has not been adequately investigated. 
Aim.  The purpose of this study was to test the relation of fine particulate matter 
with hospitalizations attributable to Ulcerative Colitis or Crohn’s Disease over a 
seven-year period in South Carolina.  
Methods. Average annual county-level fine particulate matter levels were compared 
to the annual county-level counts of in-patient hospitalizations attributable to 
Ulcerative Colitis and Crohn’s Disease from the years 2005 through 2011. A 
generalized linear mixed effects model was developed for both diseases, and 
incorporated both spatial and temporal components. 
Results. Both Ulcerative Colitis and Crohn’s Disease hospitalizations significantly 
increased across the study years, even after adjusting for differences in population 
sizes; whereas fine particulate matter significantly decreased across the study
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 years. Overall, fine particulate matter was not found to be a significant predictor 
of county-level annual hospitalizations attributable to Ulcerative Colitis or 
Crohn’s Disease across the study period.  
Conclusions. These findings did not support the tested hypothesis that fine particulate 
matter would be a significant predictor of Ulcerative Colitis or Crohn’s Disease in 
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Ulcerative Colitis [UC] and Crohn's Disease [CD] are both idiopathic conditions 
belonging to the Inflammatory Bowel Disease [IBD] family. They are immunologically 
mediated conditions of the gastrointestinal [GI] tract affecting both males and females of 
all ages and ethnicities. Most patients are diagnosed within the first three generations of 
life, and once diagnosed, they experience lifelong intermittently-recurring periods of 
active symptoms (Loftus & Sandborn, 2002). Although few individuals die from UC or 
CD, up to 15% of those diagnosed with these conditions die from colorectal cancer 
(Munkholm, 2012). While the burden of these life-long conditions continues to rise 
(Molodecky et al., 2012), we still know little as to what causes these diseases. 
 In 1859 UC became the first recognized disease in the IBD family (Wilks, 1859). 
Not for over 60 years, in 1932, was CD recognized as a separate condition (Crohn, 
Ginzburg, & Oppemjeo, 1984). Both conditions are characterized by similar symptoms: 
reoccurring periods of inflammation, bloody diarrhea and abdominal pain. The distinction 
between these diseases lies in their locations; while UC is limited to the colon and 
rectum, CD can be found anywhere along the GI tract (Baumgart, 2008).  
Cases of UC and CD, until recently, were largely limited to those living in Europe 
and North America. For UC, past research has demonstrated a prevalence of 505 and 249
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per 100,000 persons in Europe and the United States [US], respectively. But for CD, the 
prevalence has been shown to be much more similar with Europe at 322 and the US at 
319 per 100,000 persons (Molodecky et al., 2012). More recently, other developed and 
developing countries in Africa, Asia and Latin America have experienced increasing 
prevalence and incidence rates of IBD, demonstrating the shift of IBD away from a 
European and North American disease towards a global disease (Hou, El-Serag, & 
Thirumurthi, 2009). 
The historic homogeneity of individuals diagnosed with UC and CD coupled with 
a lack of identified dietary culprits misled many prior researchers to conclude that an 
individual's genetic makeup was the primary causal factor for these diseases. Recent 
advances in genome wide association studies have demonstrated that only about 25% of 
IBD cases could be explained by an individual's genetic makeup alone (Abraham & Cho, 
2009). These findings have redirected the attention of researchers towards environmental 
factors and their roles in the etiology of IBD. 
Ecological studies, although unable to properly quantify individual risks, have 
extensively been utilized by IBD researchers due to their cost effectiveness and 
hypothesis generating properties. Through these studies, a variety of group level 
environmental factors have been identified. First, a north to south gradient has been 
shown with consistently more cases being found in northern latitudes than in southern 
ones (Armitage et al., 2004; Economou & Pappas, 2008; Kappelman et al., 2007; Khalili 
et al., 2012; Nerich et al., 2006). This finding has led to several etiologic hypotheses 
including vitamin D deficiencies, dietary factors, and the use of various indoor heating 
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devices. None of these hypothesized risk factors have consistently been found to be 
associated with either CD or UC. 
Second, areas with higher average socioeconomic statuses [SES], compared to 
areas with lower SES, have been associated with increased rates of IBD (Aamodt, 
Jahnsen, et al., 2008; Armitage et al., 2004; Blanchard, Bernstein, Wajda, & Rawsthorne, 
2001; Economou & Pappas, 2008; Green, Elliott, Beaudoin, & Bernstein, 2006). This 
finding has led to investigations in lifestyle factors associated with those of higher SES 
such as increased physical activity and exercise (Bilski, Brzozowski, Mazur-Bialy, 
Sliwowski, & Brzozowski, 2014), hospital utilization (Kappelman et al., 2007), type of 
employment (Sonnenberg, 1990) and dietary factors (Geerling et al., 2000). Findings 
from these investigations have yielded conflicting results and have further diluted 
researchers understanding of these diseases. 
The third environmental factor found, is an association between those with IBD 
and urban residency (Aamodt, Jahnsen, et al., 2008; Blanchard et al., 2001; Sonnenberg, 
1990; Sonnenberg, McCarty, & Jacobsen, 1991). Even after adjusting for differences in 
population sizes, many more individuals diagnosed with either UC or CD have been 
found to live in urban, compared to rural, environments. This finding has led to 
investigations of water supplies (Aamodt, Bukholm, et al., 2008) and environmental 
pollutants (Ananthakrishnan, McGinley, Binion, & Saeian, 2011; Beamish, Osornio-
Vargas, & Wine, 2011; Kaplan et al., 2010; Salim, Kaplan, & Madsen, 2014; Tornqvist et 
al., 2007). The research behind the association of IBD with urban residency has not been 
as extensively studied as those associations with SES or latitude.  
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One of the biggest factors separating urban and rural environments is the 
population density and the resulting high concentrations of traffic related ambient air 
pollutants. According to the Environmental Protection Agency [EPA], particulate matter 
[PM] is made up of a wide variety of tiny particles such as dust, acids and metals, which 
have the ability to be suspended in the air. The density of PM is often measured in 
micrograms per cubic meter (µm3) and is split, by its size, into course particulate matter 
[PM10] or fine particulate matter [PM2.5]. The larger of the two, PM10, is between 2.5 and 
10 microns in size, and often consists of farming and agricultural byproducts. The smaller 
of the two, PM2.5, includes all particulates smaller than 2.5 microns in size and are 
associated with the combustion of fuels from certain industries and vehicle emissions 
(Laden, Neas, Dockery, & Schwartz, 2000). 
The distinction between PM10 and PM2.5 is important because of the unique health 
risks associated with each. Upon inhalation, larger particles are generally captured in the 
trachea, nasal hairs or the mucous layer of the upper respiratory system. Clearance of 
PM10 containing mucous is generally completed within 24 hours through ciliary beating, 
where the mucous is transported along the digestive tract and removed. The smaller 
particles, due to their size, can get deeper into the respiratory system, down into the lungs 
and even the alveoli, where no mucous transport system exists and the greatest damage is 
believed to take place (Calderon-Garciduenas et al., 2007). To clear PM2.5 from the 
alveoli, macrophage-mediated clearance is believed to take place, which can take several 
months for complete clearance to occur (Moller et al., 2004).  
Emerging evidence on the wide range of health effects attributable to PM2.5 have 
demonstrated the importance of PM2.5 control as a major public health issue. Beyond the 
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obvious detrimental effects on the lungs (Fan et al., 2009), increased mortality due to 
heart and vascular diseases have also been observed following periods of elevated levels 
of PM2.5 (Brook et al., 2010). Both population-based studies and animal models have 
begun to show links between PM2.5 and diseases of the gastrointestinal tract (Kaplan et 
al., 2009; Kaplan et al., 2012; Orazzo et al., 2009; Salim, Jovel, et al., 2014; Salim, 
Kaplan, et al., 2014; Tornqvist et al., 2007). Interestingly, even under mounting evidence, 
population-based studies assessing PM2.5 exposure and IBD are sparse. 
Only two population-based studies assessing the association between elevated 
exposure to PM and IBD have been conducted and have yielded discordant conclusions. 
The aim of this study was to address gaps in the current literature surrounding PM2.5 and 
IBD. Both of the previous studies were comprised of populations residing in northern 
latitudes; we decided to test the association among a population residing in a latitude 
closer to the equator, South Carolina [SC]. Although this population lacked an ongoing 
surveillance system to monitor cases of UC or CD, in-patient hospitalization records were 
utilized as the source of cases based on their availability and previously validated 
accuracy in diagnosing UC and CD (Thirumurthi, Chowdhury, Richardson, & Abraham, 
2010). Our primary research question was if the average annual levels of PM2.5 in SC 
counties were associated with emergency department in-patient hospitalizations 
attributable to UC or CD across the years 2005 through 2011. A secondary research 
question we wished to answer was if there was a statistically significant increase in in-
patient emergency department hospitalizations due to UC or CD across the years 2005 






Although, only two known epidemiologic studies have been conducted assessing 
human exposure to elevated PM as a potential risk factor for the development of IBD, 
there is strong evidence for the association through other scientific research studies. 
Other studies include mouse models assessing direct PM exposure and IBD related 
symptoms, and human studies assessing PM exposure with inflammatory biomarkers and 
nonspecific abdominal pain.  
A mouse-model was conducted in Alberta, Canada assessing exposure to PM 
during the neonatal period of life and altered colitis later in life among genetically 
susceptible mice (Salim, Jovel, et al., 2014). Pregnant Interleukin 10-/- mice were first 
randomized into a control or study group. The mice in the study group were fed a diet 
mixed with PM10 whereas the mice in the control group were fed a normal diet. The pups 
of the pregnant mice were then studied at 10, 14, and 20 weeks of age. Each study point 
consisted of approximately six control and six study mice whose intestines were removed 
and studied. Although the two groups experienced similar disease outcomes, it was 
demonstrated that the PM10 fed mice experienced an earlier onset of colitis than the mice 
fed a normal diet. Additionally, those mice fed a PM10 diet were shown to have decreased 
abilities to cope with intestinal injuries later in life compared to the mice fed a normal
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diet. Systemic inflammatory effects of PM exposure among humans was demonstrated in 
a study published in 2007 (Tornqvist et al., 2007). Researchers utilized a randomized, 
double-blind, crossover trial with 15 healthy males between the ages of 18 and 38 years. 
At two study separate study cycles, participants were exposed to either filtered air or 
diesel exhaust in a monitored chamber for a duration of one hour. During both cycles, 
participants were asked to perform bouts of moderate exercise followed by bouts of rest. 
Inflammatory markers were assessed 24 hours after each study cycle. To control for the 
possibility of a carryover of effects, the researchers included a washout period of at least 
two weeks between study cycles. The researchers found statistically significant increases 
in plasma cytokine levels, including both tumor necrosis factor alpha and interleukin-6, 
when participants were exposed to diesel exhaust compared to the filtered air. This robust 
study on a human population successfully demonstrated a significant link between an 
exposure to diesel particles, a significant contributor to PM, and markers of systemic 
inflammation.  
A study published in the October, 2012 issue of the journal PLOS ONE 
demonstrated a statistically significantly positive association between PM2.5 and non-
specific abdominal pain hospitalizations (Kaplan et al., 2012). In order to control for 
potential across-individual confounders, the authors utilized a case crossover study 
design, where each cases served as their own control. Participants included all individuals 
who were diagnosed with non-specific abdominal pain in emergency departments across 
two Canadian cities, Edmonton and Montreal, during the years 1992-2002. These 
hospitalizations were compared to daily mean concentrations of six pollutants, including 
both PM10 and PM2.5, which were gathered from fixed monitoring stations within each of 
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the study areas. Through the use of a conditional logistic regression statistical model, and 
after adjusting for temperature, relative humidity, and day of the week of hospitalization, 
individuals between the ages of 15 and 24 years were significantly more likely to be 
hospitalized for non-specific abdominal pain on days of elevated PM2.5 in both cities. 
This study provides credible evidence for environmental pollutants, such as PM2.5, having 
negative effects on the gastrointestinal tracts of susceptible individuals.  
The first, of two, population-based studies assessing the association of PM 
exposure and IBD was conducted in the United Kingdom [UK] using a nested case 
control study design (Kaplan et al., 2010). The authors examined the annual mean 
concentration of three air pollutants: PM10, sulfur dioxide, and nitrogen dioxide within 
wards of approximately 2,000 residents. After stratifying the wards into either high or 
low exposure groups (based on quintiles), a conditional logistic regression model was 
used to assess the relationship of the air pollutants and the incidence of UC and CD. 
Overall, none of the air pollutants were associated with the incidence of IBD; but among 
those 23 years of age or younger, those who lived in areas with higher nitrogen dioxide 
levels were associated with CD but not UC. Also, for UC, but not CD, those 25 years of 
age and younger were more likely to live in areas of high sulfur dioxide levels. No 
association between PM10 and either UC or CD incidence were observed, even in the sub-
analyses. 
The second study, was conducted in the northern U.S., Wisconsin, used an 
ecological analysis at the county level to examine the association of ambient air 
pollutants and IBD hospitalizations (Ananthakrishnan et al., 2011). This study included 
five air pollutants: volatile organic compounds, carbon monoxide, nitrous oxide, sulfur 
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dioxide, and PM2.5. Using a Poisson regression model, the authors found statistically 
significant positive associations between each of the five air pollutants and both UC and 
CD hospitalizations. 
Strong evidence for elevated PM exposure as a risk factor for IBD exists through 
a variety of studies. But, the only two known population-based studies assessing the 
relationship between PM exposure with IBD differed substantially, not only in their 
design, but also in their results. This lack of concordance between the two studies has left 






3.1 Study Population 
 All persons living in SC from the years 2005 through 2011 were included in the 
study and considered at risk of being hospitalized due to UC or CD. Individuals living in 
neighboring states who were employed in SC, were not included in the study population.  
3.2 Data Sources 
 In-patient hospitalization records for CD and UC were obtained through the South 
Carolina Revenue and Fiscal Affairs office. Cases were determined according to the 
International Classification of Diseases, 9th edition (ICD-9) codes for CD (555.x) and UC 
(556.x). Each case included county of residence, age group, sex, ethnicity, and year of 
diagnosis from the years 2005 through 2011. Only cases with complete information were 
retained for all analyses. The U.S. Census Bureau provided population counts for all SC 
Counties for each of the study years. The population counts for the years 2005-2009 and 
2011 were estimated counts while the 2010 census was used for the year 2010. 
 The Outdoor Air Quality – Fine Particulate Matter database, downloaded through 
CDC Wonder, was used for the PM2.5 exposure data. The data are results of a regional
11 
 
 surfacing algorithm developed by the National Aeronautics and Space Administration 
[NASA] Applied Sciences and Public Health programs. Incorporated into the algorithm
 were direct land monitored PM2.5 data from the United States Environmental Protection 
Agency [EPA] Air Quality System along with remotely sensed aerosol optical depth data 
from the NASA moderate Resolution Imaging Spectroradiometer. Fine Particulate matter 
levels were measured in micrograms per cubic meter (µg/m3), and given as annual 
average county-level estimates. 
3.3 Rate Standardization 
 According to the U.S. Census Bureau, in 2005 McCormick County had a 
population of only 10,049, while Greenville County had a population of 405,608. By 
using traditional disease rates, counties with smaller populations, such as McCormick 
County, would be much more susceptible to large and inconsistent rate fluctuations from 
year to year than larger counties, such as Greenville County. Similarly, the age 
distributions across SC counties varied from a median age of 32 years in Richland 
County to 50 years in McCormick County. Since UC and CD are generally diagnosed 
within the first 40 years of life (Nerich et al., 2006), comparing counties with different 
age distributions would yield biased results.  In order to address the heterogeneity of 
population sizes and age distributions across SC counties, UC and CD rates were 
standardized using the indirect standardization method (Naing, 2000). For each study 
year and county, all cases and base populations were split into three broad age categories: 
less than 20 years, between 20 and 64 years, and 65 years or older. Expected counts were 
calculated through an internal standard population rate, which was the aggregate SC 
hospitalization rates for each year and disease. The standardized morbidity ratio (SMR) 
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was then calculated by dividing the observed cases by the expected. All rate 
standardizations were calculated using the STDRATE procedure in SAS software (SAS. 
Version 9.4, SAS Institute, Cary, NC).  
3.4 Data Visualization 
 The results of the SMR calculations were then displayed on maps of SC using the 
ArcGIS software (ESRI 2011. ArcGIS Desktop: Release 10. Redlands, CA: 
Environmental Systems Research Institute). The SMRs that were significantly different 
than expected, based on p-values less than 0.05, were displayed on each of the maps. 
Separate maps were developed for UC and CD for each study year, which yielded 14 
individual maps. 
3.5 Analysis 
 To guide the analytic strategy, the Global Moran’s I test for spatial 
autocorrelation was first performed using ArcGIS software. The test used row 
standardized values of the SMRs for each county and was based off of the Queen spatial 
weights matrix. Failing to account for spatial autocorrelation, if present, could have 
potentially led to biased results. 
In the primary effects model, the counts of UC and CD within each county were 
treated as the dependent outcome variables. Because these variables could never take on a 
negative value, it would have been inappropriate to use any model that was based on the 
normal distribution assumption. To account for this non-negative problem, it was decided 
that either a Poisson or Negative Binomial distribution model should be used. 
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A Poisson distribution model consists of a single parameter, Lambda, which 
represents both the mean and the variance of the model. When the variance is greater than 
the mean, as is often the case when investigating rare diseases, overdispersion is present. 
Continuing to use the Poisson model with overdispersion would lead to biased results. To 
test for overdispersion, the SAS procedure GENMOD was used. If zero was contained in 
the Wald 95% Confidence Limits for the Dispersion parameter, overdispersion would not 
have been present and a Poisson regression model would have been selected. If zero was 
not contained, the Negative Binomial distribution model would have been used.  
It was determined that the SAS procedure GLIMMIX would be used for the 
primary analyses. This procedure was chosen based on its flexibility to use either a 
Poisson Regression or a Negative Binomial model, while incorporating random effects 
and spatial components if autocorrelation was present. From this procedure, two primary 
effects models were constructed. The first for UC and the second for CD, modeled the 
number of cases as the dependent variable, PM2.5 (continuous), Year (continuous), and 
the interaction of the two as the independent variables. The log of the expected cases was 
used as the offset parameter. The covariance structure of the model was determined 
through the results of the global Moran’s I test. In the presence of spatial autocorrelation, 
the sp(exp) Latitude Longitude option would have been used, while the unstructured 
option would have been used if spatial autocorrelation were not detected.  
3.6 Covariate Adjustment 
 In two additional models, seven potential county level confounders were assessed 
in both of the main effects models for UC and CD. Potential confounders included: 
percent of residents in each county with no high school diploma, percent of the residents 
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in each county who were non-Hispanic white, the median age of residence within each 
county, the average household size within each county, the percent of the residents in 
each county who smoked cigarettes, the percent of residence within each county who 
lived in poverty, and the percent of individuals within each county who were female. A 
backwards selection procedure was used in both models to determine if each of the 
potential confounder should be included in each of the final model. The initial adjusted 
model for each disease included all potential confounders. Each time the model was ran 
and analyzed, the potential confounder with the highest p-value was removed. The final 
adjusted models for UC and CD included only the covariates that had a p-value less than 







From 2005 to 2011 there were 21,660 in-patient hospitalizations from either UC 
or CD. Characteristics of patients are outlined in Table 4.1. Over the study period there 
were over two times the amount of hospitalizations attributable to CD (n=14,914) than 
there were UC (n=6,746). The average annual UC hospitalizations increased at a rate of 
0.70 cases per 100,000 population per year (p=0.001), from 19.37 (95% CI=17.09, 21.65) 
in 2005 to 23.48 (95% CI=19.97, 27.00) in 2011. Rates of CD increased by 1.64 cases 
per 100,000 population per year (p=0.002) from 40.52 (95% CI=35.61, 45.43) in 2005 to 
48.16 (95% CI=41.24, 55.09) in 2011. Both gender and racial distributions of UC and CD 
remained constant over the study period while the proportion of those between the ages 
of 20 and 64 years significantly decreased and those 65 years or older significantly 
increased. 
Average annual levels of PM2.5 decreased by 0.34 µg/m
3 per year (p<0.0001) in 
SC over the study period. The highest mean levels of PM2.5 were in the year 2005 (Mean 
14.45, SD 0.7187), while the lowest mean levels were in the year 2009 (Mean 11.6924, 
SD 0.17714). A graphical representation of the changes in UC and CD hospitalizations 




The SC counties that had a SMR that was significantly different than expected for 
UC and CD during each of the study years are displayed on maps in Figure 4.2 and 
Figure 4.3, respectively. Significant spatial autocorrelation was detected for Crohn’s 
Disease in 2007 (Z=1.974, P=0.048) and 2008 (Z=2.521, P=0.012). No spatial 
autocorrelation was detected for UC. Results of the GENMOD procedure indicated 
overdispersion for both UC and CD across all study year. As a result, the negative 
binomial distribution model was chosen over the poisson regression model for all 
analyses. The results of the random effects statement within both the UC and CD models 
indicated a statistically significant (p-value <0.0001) difference in the population 
adjusted number of hospitalizations attributable to UC or CD across SC counties.  
None of the main effects models, crude or adjusted, indicated that the annual 
average levels of PM2.5 were associated with UC or CD in-patient hospitalizations. After 
the backwards elimination selection procedure, the final adjusted models for UC and CD 
differed in the confounders included in each. The percent of the population within each 
county who were female was a significant confounder for both models, while the percent 
of each county who were non-Hispanic white was significant for CD only. Results of the 







Table 4.1. Summary of demographic statistics for Ulcerative Colitis and Crohn’s Disease 
Hospitalizations in South Carolina, 2005-2011 
 
 Year  
 2005 2006 2007 2008 2009 2010 2011 P-value€ 
Cases, no.         
CD 1,800 1,811 1,838 2,244 2,352 2,461 2,408 0.0023 
UC 822 772 906 1,016 1,008 1,049 1,173 0.0011 
Gender, %         
Female         
CD 61.28 58.97 59.30 60.03 60.80 60.59 59.68 0.9906 
UC 55.11 55.57 57.73 56.69 56.75 57.10 55.84 0.4329 
Race, %         
White         
CD 78.17 78.41 76.88 78.83 78.61 75.74 77.37 0.3532λ 
UC 77.86 79.27 78.81 79.33 81.25 75.98 76.04 0.3869λ 
A-A†         
CD 20.72 20.38 20.95 19.43 20.15 22.55 20.72 0.5353 
UC 19.34 18.52 17.66 19.09 16.77 21.54 21.74 0.2389 
Other         
CD 1.11 1.21 2.18 1.74 1.23 1.71 1.91 0.2931 
UC 2.80 2.20 3.53 1.57 1.98 2.48 2.22 0.4636λ 
Age, %         
< 20         
CD 4.50 3.92 5.77 5.30 4.04 4.35 4.19 0.6661λ 
UC 5.96 5.70 4.19 5.91 5.65 3.34 4.18 0.1328λ 
20-64         
CD 76.17 79.51 75.46 73.35 73.89 72.86 72.43 0.0263λ 
UC 63.99 68.52 66.45 62.89 63.19 61.49 60.44 0.0429λ 
≥ 65         
CD 19.33 16.57 18.77 21.35 22.07 22.80 23.38 0.0103 
UC 30.05 25.78 29.36 31.20 31.15 35.18 35.38 0.0174 
† African America 
€ Test of trend 






Table 4.2: Crude and Adjusted Main Effects Model Results for Ulcerative Colitis and Crohn’s 




Estimate (P value) 
Crohn’s Disease 
Estimate (P value) 
 Crude Adjusted Crude Adjusted 
Intercept 0.397 (0.488) -4.126 (0.018) -0.029 (0.948) -5.586 (0.001) 
PM2.5 -0.035 (0.390) -0.036 (0.379) -0.007 (0.827) -0.010 (0.762) 
YEAR -0.082 (0.584) -0.085 (0.573) -0.021 (0.853) -0.019 (0.865) 
PM2.5*YEAR 0.005 (0.640) 0.006 (0.628) 0.001 (0.895) 0.001 (0.915) 
FEMALE%† - 8.874 (0.006) - 9.900 (0.002) 
NHW%€ - - - 0.940 (0.010) 
† Percent of the population within each SC county that are female 


















Our data did not indicate that average annual levels of PM2.5 had any impact on 
UC or CD hospitalizations in SC from the years 2005 through 2011. Rates of UC and CD 
in-patient hospitalizations were found to be steadily increasing while the annual levels of 
PM2.5 were found to be decreasing. Even when the temporality aspects of our data were 
ignored, counties with highest levels of PM2.5 were not the same counties with the highest 
levels of in-patient UC or CD hospitalizations.  
The lack of association between fine particulate matter and UC or CD in-patient 
hospitalizations demonstrated in our study strengthen the inferences made by Kaplan et 
al. who also was unable to find a statistically significant association between air 
pollutants and UC or CD. Even though a more similar study design, the results of our 
study do not support those from Ananthakrishnan et al.. Our studies differed primarily in 
the number of variables accounted for and the analyses performed. While our study 
concentrated solely on levels of PM2.5, Ananthakrishnan et al. investigated five separate 
environmental pollutants along with PM2.5. Also, the study by Ananthakrishnan et al. 





Several limitations should be considered. First, the ecological nature of the study 
did not allow for inferences to be made about individuals. Second, aggregate 
administrative based ICD-9 codes were used for case ascertainment. Without validation, 
this source of case data is prone to disease misclassification. Also, the aggregate-level 
data limited our ability to control for rehospitalizations, thus making our study 
susceptible to cases being counted multiple times. Third, no individual-level monitoring 
of PM2.5 was conducted. This limitation assumed that everyone in a particular county 
received the same level of exposure to PM2.5 regardless if they were employed in the 
same county or if they spent most of their time indoors, opening up the possibility of 
exposure misclassification. Lastly, the use of annual average PM2.5 did not capture 
seasonal variations or acute spikes brought on by fires and other industrial sources that 
could have potentially led to acute spikes in UC or CD hospitalizations.  
A few strengths of the study were also evident. First, in-patient hospitalizations 
and levels of PM2.5 were monitored over a seven-year period allowing for temporality to 
be assessed and trends to be demonstrated. Second, a geostatistical analysis was utilized, 
which accounted for the spatial autocorrelation exhibited by our data. Third, our study 
consisted of a relatively large sample size which allowed for sub-analyses to be 
performed.  
The results from this study did not indicate any association between rates of UC 
or CD hospitalizations and PM2.5. Rates of UC and CD were observed to be increasing 
over the seven-year period while levels of PM2.5 decreased. In order to rule out PM2.5 as a 
potential piece in the complex web of causation of UC and CD, future studies would need 
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to include more individual-level monitoring of PM2.5 and a more accurate case 
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